These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 8901758

  • 1. Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year.
    Chau EM, Bailey KR, Mahoney DW, Frantz RP, McGregor CG, Daly RC, Edwards BS, Olson LJ, Rodeheffer RJ.
    Circulation; 1996 Nov 01; 94(9 Suppl):II267-72. PubMed ID: 8901758
    [Abstract] [Full Text] [Related]

  • 2. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation.
    Erickson KW, Costanzo-Nordin MR, O'Sullivan EJ, Johnson MR, Zucker MJ, Pifarré R, Lawless CE, Robinson JA, Scanlon PJ.
    J Heart Transplant; 1990 Nov 01; 9(5):526-37. PubMed ID: 2231091
    [Abstract] [Full Text] [Related]

  • 3. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec 01; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 4. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.
    Bourge RC, Kirklin JK, Naftel DC, White C, Mason DA, Epstein AE.
    J Thorac Cardiovasc Surg; 1991 Mar 01; 101(3):432-44; discussion 444-5. PubMed ID: 1999936
    [Abstract] [Full Text] [Related]

  • 5. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events].
    Frigerio M, Gronda E, Danzi GB, Mangiavacchi M, Oliva F, Quaini E, Trotta E, De Vita C, Pellegrini A.
    G Ital Cardiol; 1995 Jan 01; 25(1):1-9. PubMed ID: 7642005
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W, Costard-Jaeckle A, Stempfle HU, Deng MC, Schwaab B, Haaff B, Naegele H, Mohacsi P, Trautnitz M, PROPHET Study Group.
    J Heart Lung Transplant; 2006 Sep 01; 25(9):1070-6. PubMed ID: 16962468
    [Abstract] [Full Text] [Related]

  • 7. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation.
    Butler J, Stankewicz MA, Wu J, Chomsky DB, Howser RL, Khadim G, Davis SF, Pierson RN, Wilson JR.
    J Heart Lung Transplant; 2005 Feb 01; 24(2):170-7. PubMed ID: 15701433
    [Abstract] [Full Text] [Related]

  • 8. [Pulmonary hypertension and early mortality after orthotopic heart transplantation].
    López-Ciudad VJ, López Pérez JM, Fojón Polanco S, Blanco Sierra FJ, Pradas Montilla G, Cuenca Castillo JJ, Vázquez González N, Hermida Alvarez LF.
    Rev Esp Cardiol; 1995 Aug 01; 48(8):552-6. PubMed ID: 7644809
    [Abstract] [Full Text] [Related]

  • 9. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
    Klotz S, Wenzelburger F, Stypmann J, Welp H, Drees G, Schmid C, Scheld HH.
    Ann Thorac Surg; 2006 Nov 01; 82(5):1770-3. PubMed ID: 17062245
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation.
    Zales VR, Pahl E, Backer CL, Crawford S, Mavroudis C, Benson DW.
    J Heart Lung Transplant; 1993 Nov 01; 12(6 Pt 1):965-72; discussion 972-3. PubMed ID: 8312321
    [Abstract] [Full Text] [Related]

  • 11. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM, Dembitsky WP, Jaski BE, Daily PO, Moreno R, Kim JC, Sono J, Akasaka T, Hoagland PM, Gordon JB.
    ASAIO J; 1997 Nov 01; 43(4):365-9. PubMed ID: 9242955
    [Abstract] [Full Text] [Related]

  • 12. Predictors of early mortality after heart transplantation: the Canadian transplant experience from 1981 to 1992. The CASCADE Investigators. Canadian Study of Cardiac Transplant Atherosclerosis Determinants.
    Carrier M, Rivard M, Latter D, Kostuk W.
    Can J Cardiol; 1998 May 01; 14(5):703-7. PubMed ID: 9627527
    [Abstract] [Full Text] [Related]

  • 13. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure.
    Maruszewski M, Zakliczyński M, Przybylski R, Kucewicz-Czech E, Zembala M.
    Transplant Proc; 2007 Nov 01; 39(9):2850-2. PubMed ID: 18021999
    [Abstract] [Full Text] [Related]

  • 14. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L, Grimm M, Rajek A, Wolner E, Wieselthaler G.
    J Thorac Cardiovasc Surg; 2007 Mar 01; 133(3):689-95. PubMed ID: 17320566
    [Abstract] [Full Text] [Related]

  • 15. Effect of different pharmacologic agents to reverse severe pulmonary hypertension among end-stage heart failure patients.
    Torres Macho J, Delgado Jimenez JF, Sanz Salvo J, Gonzalez Mansilla A, Sanchez Sanchez V, Gamez Diez S, Escribano Subias P, Saenz de la Calzada C.
    Transplant Proc; 2009 Mar 01; 41(6):2477-9. PubMed ID: 19715956
    [Abstract] [Full Text] [Related]

  • 16. [Hemodynamic characteristics of heart transplant patients in the early postoperative period].
    Dammenhayn L, Haverich A, Coppola R, Albes J, Cremer J, Schäfers HJ, Wahlers T.
    Z Kardiol; 1991 Nov 01; 80(11):681-6. PubMed ID: 1792810
    [Abstract] [Full Text] [Related]

  • 17. Preoperative pulmonary hemodynamics and assessment of operability: is there a pulmonary vascular resistance that precludes cardiac operation?
    Giglia TM, Humpl T.
    Pediatr Crit Care Med; 2010 Mar 01; 11(2 Suppl):S57-69. PubMed ID: 20216166
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of pulmonary hypertension reversibility test with sodium nitroprusside in stratification of early death risk after orthotopic heart transplantation.
    Zakliczynski M, Zebik T, Maruszewski M, Swierad M, Zembala M.
    Transplant Proc; 2005 Mar 01; 37(2):1346-8. PubMed ID: 15848716
    [Abstract] [Full Text] [Related]

  • 19. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality.
    Chang PP, Longenecker JC, Wang NY, Baughman KL, Conte JV, Hare JM, Kasper EK.
    J Heart Lung Transplant; 2005 Aug 01; 24(8):998-1007. PubMed ID: 16102433
    [Abstract] [Full Text] [Related]

  • 20. Elevated pulmonary vascular resistance and cardiac transplantation.
    Addonizio LJ, Gersony WM, Robbins RC, Drusin RE, Smith CR, Reison DS, Reemtsma K, Rose EA.
    Circulation; 1987 Nov 01; 76(5 Pt 2):V52-5. PubMed ID: 3311456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.